In this review
An expanded identity still needs a defined purpose
Polly’s official rebrand says it continues Piper’s service while expanding its wellness scope. The current catalogue actually names compounded semaglutide and tirzepatide, NAD+ and sermorelin. That establishes product availability to investigate, not that several prescriptions belong in one preventive plan. [1] [2]
The NAD+ and sermorelin help pages describe use alongside GLP-1 care. Confirm access eligibility and the complete selected arrangement; the descriptions do not establish a universal standalone or mandatory-base-plan offer. A different prescription should not be started merely to obtain an add-on. [17] [19]
Compare the defined clinical role in our health-service comparisons.
Identify the actual clinical relationship
Polly provides access and administrative support while independent professionals provide medical and pharmacy services. The home page names possible 503A partners, but the actual prescriber, dispenser and formulation depend on the selected care arrangement. [2] [3]
Ask who interprets concerns, what monitoring is included and what would prompt reconsidering treatment. Portal access and delivery updates are useful services, but do not constitute comprehensive preventive care or prove that multiple prescriptions improve a person’s overall health.
For another metabolic-care and add-on arrangement, read our OrderlyMeds review.
Keep every paid term attached to its product
Monthly semaglutide and tirzepatide are listed at $179 and $279, while the latter’s six-month $199 equivalent requires $1,194 upfront. NAD+ injection has a $199 monthly or $549 three-month upfront option; sermorelin has $229 or $537. These are separate purchases, not one health-program price. [11] [12] [16] [18]
Nasal NAD+ is separately priced, and longer supplies can arrive together. Confirm the actual route, quantity, usable period, any required base purchase and additional assessment before estimating a complete commitment. A discounted equivalent should not conceal how much cash is due now. [16]
Separate the actual paid commitments in the full care-cost planner.
Match the outcome to the actual preparation
The NAD+ FAQ connects a coenzyme and delivery routes with energy and focus; the sermorelin FAQ connects hormonal signaling with sleep and recovery. Those explanations do not establish improved function, fewer clinical events or longer healthy life from the selected preparations or their combination. [17] [19]
The GLP-1 articles acknowledge the compounds are not FDA-approved and may have different added ingredients. FDA recommends compounded GLP-1 use for needs an approved drug cannot meet. Branded-product outcomes and pharmacy credentials cannot supply finished-product evidence for a different intervention. [10] [13] [14] [15]
Keep product and population attached to the SELECT cardiovascular evidence.
Distinguish measured outcomes with lean mass and physical function.
Treat cancellation and a refund as separate actions
The formal policy generally allows an order refund before pharmacy submission and excludes it after transmission. Plan cancellation stops future renewal after confirmation; ordinary unused time is not prorated. Specific ineligibility, verified billing errors and damaged-delivery exceptions are narrower than a result-based guarantee. [4]
Later help articles describe discretionary adjustments for unused supply and loss of a multi-month discount on early exit. Resolve the selected agreement before prepaying rather than assume a first-month trial or a guaranteed unused balance. Card authorization before approval is also different from a refund after prescribed treatment. [6] [7] [8]
For another catalogue and financial-exit arrangement, compare our Raeliva review.
Compare a useful addition to existing care
The general refill guidance describes processing around every 25 days. The shipping policy separates approval, preparation and expedited transit; an overnight carrier service is not immediate access to a clinician or a guarantee of next-day arrival after ordering. [5] [8]
I would compare Polly after identifying the clinical question and the actual service that helps address it. A broader wellness label is less persuasive than a coherent purpose, useful follow-up and a complete selected bill. Additional prescriptions should earn their place individually, rather than turn uncertainty into a longevity promise.
Consider continuity alongside the evidence after GLP-1 treatment stops.
For a different virtual primary-care and preventive-care role, read our PlushCare review.
For a contrasting prescription, pharmacy and paid-term arrangement, read our Pomegranate Health review.
Understanding the cost
Semaglutide $179 monthly and tirzepatide $279; longer terms are prepaid, including explicit six-month tirzepatide total $1,194. NAD+ injection $199 monthly or $549 upfront for three months, nasal spray $199 monthly. Sermorelin $229 monthly or $537 upfront for three months. Adjunct eligibility, any base-plan requirement and the complete selected care total need confirmation. [7] [11] [12] [16] [18]
Build your cost estimateSources
- Polly: official Piper rebrand and account continuity
- Polly: current treatment catalogue and pharmacy relationships
- Polly: April 29, 2026 clinical, subscription and payment terms
- Polly: cancellation, pharmacy-submission cutoff and refund exceptions
- Polly: pharmacy preparation, carrier service and shipping concerns
- Polly: card authorization and payment after approval
- Polly: upfront multi-month billing and discount adjustments
- Polly: pausing, cancellation, reviewed refunds and auto-refill cycle
- Polly: included care, supplies and payment-method limits
- FDA: compounded medicines and premarket-review limits
- Polly: semaglutide monthly and multi-month equivalents
- Polly: tirzepatide rates and six-month upfront total
- Polly: semaglutide formulation, supplied items and compounding status
- Polly: tirzepatide formulation, supplied items and compounding status
- FDA: concerns with unapproved GLP-1 medicines
- Polly: NAD+ injection and nasal spray prices
- Polly: NAD+ routes and adjunct-treatment description
- Polly: sermorelin monthly and upfront three-month charges
- Polly: sermorelin mechanism and adjunct-treatment description
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.